用局部多贝斯酸清除脂溢性角化病。
Clearance of seborrhoeic keratoses with topical dobesilate.
作者信息
Cuevas Pedro, Angulo Javier, Salgüero Irene, Giménez-Gallego Guillermo
机构信息
Departamento de Investigación, Servicio de Histología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
出版信息
BMJ Case Rep. 2012 Jun 21;2012:bcr0120125628. doi: 10.1136/bcr.01.2012.5628.
Abstract
A patient with two seborrhoeic keratoses in the face received a single daily application of dobesilate cream during 6 months. Dobesilate achieved complete clearance of the seborrhoeic keratosis lesions with good cosmoses, suggesting that this compound is a safe and efficient candidate in the treatment of seborrhoeic keratoses.
摘要
一名面部有两个脂溢性角化病的患者在6个月内每天涂抹一次多贝斯乳膏。多贝斯使脂溢性角化病皮损完全消退，且外观良好，这表明该化合物是治疗脂溢性角化病的一种安全有效的选择。
相似文献
1
Clearance of seborrhoeic keratoses with topical dobesilate.
BMJ Case Rep. 2012 Jun 21;2012:bcr0120125628. doi: 10.1136/bcr.01.2012.5628.
2
Topical treatment of actinic keratoses with potassium dobesilate 5% cream. a preliminary open-label study.
Eur J Med Res. 2011 Feb 24;16(2):67-70. doi: 10.1186/2047-783x-16-2-67.
3
Hydrogen Peroxide Topical Solution, 40% (w/w) for the Treatment of Seborrheic Keratoses: A Review.
Skin Therapy Lett. 2020 Jan;25(1):1-4.
4
Topical calcipotriol is not effective in facial seborrhoeic dermatitis.
J Dermatolog Treat. 2001 Sep;12(3):179. doi: 10.1080/09546630152608339.
5
Treatment of facial actinic keratoses with a cream containing octatrienoic acid: a multicenter clinical experience.
G Ital Dermatol Venereol. 2018 Dec;153(6):860-865. doi: 10.23736/S0392-0488.18.06064-9. Epub 2018 Jun 29.
6
Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review.
J Dermatolog Treat. 2023 Dec;34(1):2133532. doi: 10.1080/09546634.2022.2133532. Epub 2022 Nov 13.
7
Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole.
Br J Dermatol. 1987 Feb;116(2):217-21. doi: 10.1111/j.1365-2133.1987.tb05815.x.
8
A novel topical agent in the treatment of seborrheic keratoses: A proof of concept study by clinical and dermoscopic evaluation.
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12526. Epub 2017 Aug 10.
9
Unusual clinical manifestation of seborrheic keratosis on the scalp successfully treated with topical trichloroacetic acid: an atypical case report.
Pan Afr Med J. 2020 Sep 28;37:98. doi: 10.11604/pamj.2020.37.98.26090. eCollection 2020.
10
Ivermectin 1% Cream (Soolantra) for Inflammatory Lesions of Rosacea.
Am Fam Physician. 2016 Sep 15;94(6):512-3.
引用本文的文献
1
An exophytic and symptomatic lesion of the labial mucosa diagnosed as labial seborrheic keratosis.
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2749-2752. eCollection 2019.
2
Patient Preferences and Comparative Outcomes Regarding Cryosurgery versus Electrodesiccation in the Removal of Truncal Seborrheic Keratoses.
J Clin Aesthet Dermatol. 2019 Sep;12(9):E53-E56. Epub 2019 Sep 1.
3
Recent advances in managing and understanding seborrheic keratosis.
F1000Res. 2019 Aug 28;8. doi: 10.12688/f1000research.18983.1. eCollection 2019.
4
Seborrheic Keratoses - The Most Common Benign Skin Tumor of Humans. Clinical presentation and an update on pathogenesis and treatment options.
Open Access Maced J Med Sci. 2018 Nov 23;6(11):2270-2275. doi: 10.3889/oamjms.2018.460. eCollection 2018 Nov 25.
5
Diclofenac gel may be a new treatment option for seborrheic keratosis.
Indian Dermatol Online J. 2016 May-Jun;7(3):211-2. doi: 10.4103/2229-5178.182363.
本文引用的文献
1
Topical treatment of contact dermatitis by pine processionary caterpillar.
BMJ Case Rep. 2011 Aug 11;2011:bcr0620114351. doi: 10.1136/bcr.06.2011.4351.
2
Efficacy of the fibroblast growth factor inhibitor 2,5-dihydroxyphenylsulfonate in basal cell carcinoma: a histopathological and inmunohistochemical study.
J Dermatolog Treat. 2011 Dec;22(6):348-52. doi: 10.3109/09546634.2010.551108. Epub 2011 Jul 14.
3
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors.
J Biol Chem. 2010 Apr 9;285(15):11714-29. doi: 10.1074/jbc.M109.064618. Epub 2010 Feb 9.
4
Seborrheic keratosis.
J Dtsch Dermatol Ges. 2008 Aug;6(8):664-77. doi: 10.1111/j.1610-0387.2008.06788.x.
5
Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Br J Dermatol. 2008 Jul;159(1):214-7. doi: 10.1111/j.1365-2133.2008.08626.x. Epub 2008 Jul 1.
6
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13450-4. doi: 10.1073/pnas.0705218104. Epub 2007 Aug 2.
7
Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses.
J Invest Dermatol. 2007 Aug;127(8):1883-5. doi: 10.1038/sj.jid.5700804. Epub 2007 Mar 29.
8
Therapeutic response of rosacea to dobesilate.
Eur J Med Res. 2005 Oct 18;10(10):454-6.
9
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
Mol Cell. 2000 Sep;6(3):743-50. doi: 10.1016/s1097-2765(00)00073-3.
10
The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency?
Br J Dermatol. 1997 Sep;137(3):411-4.
Zotero 插件